These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26032153)

  • 1. Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus.
    Yachimski P; Maqbool S; Bhat YM; Richter JE; Falk GW; Vaezi MF
    Am J Gastroenterol; 2015 Aug; 110(8):1143-8. PubMed ID: 26032153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
    Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
    Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.
    Vaezi MF; Richter JE
    Surgery; 1995 Jun; 117(6):699-704. PubMed ID: 7778033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.
    Gerson LB; Mitra S; Bleker WF; Yeung P
    Aliment Pharmacol Ther; 2012 Apr; 35(7):803-9. PubMed ID: 22356659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is duodeno-gastro-esophageal reflux just a bystander of acid reflux?].
    Fein M; Fuchs KH; Freys SM; Maroske J; Tigges H; Thiede A
    Zentralbl Chir; 2002 Dec; 127(12):1068-72. PubMed ID: 12529822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
    Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
    Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T; Shimatani T; Sugimoto M; Ishihara S; Fujiwara Y; Kusano M; Koike T; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.
    Champion G; Richter JE; Vaezi MF; Singh S; Alexander R
    Gastroenterology; 1994 Sep; 107(3):747-54. PubMed ID: 8076761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.
    Garrean CP; Zhang Q; Gonsalves N; Hirano I
    Am J Gastroenterol; 2008 Jul; 103(7):1631-7. PubMed ID: 18557714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice.
    Vaezi MF; Richter JE
    Hepatogastroenterology; 1999; 46(25):40-7. PubMed ID: 10228763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.